What is Zacks Research’s Forecast for Clorox Q2 Earnings?

The Clorox Company (NYSE:CLX) – Research analysts at Zacks Research dropped their Q2 2025 earnings per share (EPS) estimates for Clorox in a report issued on Wednesday, November 13th. Zacks Research analyst R. Lohia now anticipates that the company will post earnings per share of $1.39 for the quarter, down from their previous forecast of $1.56. The consensus estimate for Clorox’s current full-year earnings is $6.85 per share. Zacks Research also issued estimates for Clorox’s Q3 2025 earnings at $1.68 EPS, Q4 2025 earnings at $1.92 EPS, FY2025 earnings at $6.85 EPS, Q2 2026 earnings at $1.69 EPS, Q3 2026 earnings at $1.83 EPS, Q4 2026 earnings at $1.90 EPS, FY2026 earnings at $7.17 EPS, Q1 2027 earnings at $1.81 EPS and FY2027 earnings at $7.56 EPS.

Several other research firms also recently commented on CLX. Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Evercore ISI lowered their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. JPMorgan Chase & Co. boosted their target price on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research note on Friday, October 11th. Finally, DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. Five analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $155.00.

Clorox Trading Up 0.2 %

Shares of CLX stock opened at $165.74 on Friday. Clorox has a fifty-two week low of $127.60 and a fifty-two week high of $169.09. The company has a 50 day moving average price of $162.38 and a 200 day moving average price of $147.21. The stock has a market capitalization of $20.52 billion, a P/E ratio of 57.75, a price-to-earnings-growth ratio of 3.06 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00.

Clorox (NYSE:CLX) last announced its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. Clorox’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same period last year, the business posted $0.49 EPS.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.94%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 170.04%.

Insider Activity at Clorox

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Clorox

Several institutional investors have recently made changes to their positions in the stock. State Board of Administration of Florida Retirement System lifted its position in shares of Clorox by 4.1% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 150,011 shares of the company’s stock valued at $23,738,000 after acquiring an additional 5,936 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. increased its position in shares of Clorox by 9.4% in the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 186,301 shares of the company’s stock valued at $28,525,000 after buying an additional 16,012 shares in the last quarter. Mizuho Markets Americas LLC raised its stake in shares of Clorox by 93.7% during the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after buying an additional 34,864 shares during the last quarter. First Foundation Advisors acquired a new stake in Clorox in the 1st quarter valued at about $31,000. Finally, Mitsubishi UFJ Trust & Banking Corp increased its holdings in Clorox by 24.3% during the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 181,772 shares of the company’s stock valued at $27,711,000 after acquiring an additional 35,477 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.